NCT05908201 is a NA clinical trial of early time restricted eating in Time Restricted Eating, sponsored by University of Mississippi, Oxford.

Who is sponsoring NCT05908201?

NCT05908201 is sponsored by University of Mississippi, Oxford.

What drugs are being tested in NCT05908201?

Interventions in NCT05908201: early time restricted eating.

What condition does NCT05908201 study?

NCT05908201 studies Time Restricted Eating.

Is NCT05908201 still recruiting?

NCT05908201 is currently status unknown. Last updated 18 June 2023.

Last reviewed 2023-06-18 · How we verify

NCT05908201

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Early Time Restricted Eating on Muscle Performance in Resistance Trained Individuals

Status unknown NA Last updated 18 June 2023

What this trial tests

NA trial testing early time restricted eating in Time Restricted Eating in 40 participants. Status unknown.

Timeline

20 February 2023

Primary endpoint
31 December 2023

31 May 2024

Quick facts

Lead sponsor	University of Mississippi, Oxford
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	20 February 2023
Primary completion	31 December 2023
Estimated completion	31 May 2024
Sites	1 location across United States

Drugs / interventions tested

early time restricted eating

Conditions studied

Time Restricted Eating — all drugs for Time Restricted Eating →

Sponsor

University of Mississippi, Oxford

Who can join

Adults 18 to 50, any sex, with Time Restricted Eating. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled trial to determine the effectiveness of early time-restricted eating on muscle performance and body composition in active, resistance trained adults. Two parallel groups will be randomly assigned to either the early time-restricted eating or a control group. All participants will be asked to maintain their usual exercise routines during the 6 week intervention period. Muscle strength and endurance are the primary outcomes. Body composition (body weight, fat mass, fat-free mass and percent body fat), hunger and satiety ratings, sleep quality, energy intake, diet quality, macronutrient composition and adherence are secondary outcome measures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Time-restricted eating: Watching the clock to treat obesity.
Ezpeleta M, Cienfuegos S, Lin S, Pavlou V, et al · · 2024 · cited 83× · PMID 38176412 · DOI 10.1016/j.cmet.2023.12.004

Verify or expand the search:

Other recruiting trials for Time Restricted Eating

Currently open trials in the same condition.

NCT07203196 — Circadian Health Regulation and Optimization for Rejuvenation Outcomes · NA · active not recruiting
NCT06891352 — Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers · NA · recruiting
NCT06555406 — Healthy Lifestyles in Bipolar Disorder: Bay Area Study · NA · recruiting
NCT06477120 — Time-restricted Eating Among Pregnant Females With Severe Obesity · NA · recruiting
NCT06188754 — Healthy Lifestyles for Bipolar Disorder · NA · recruiting

Other University of Mississippi, Oxford trials

Trials by the same sponsor.

NCT06695988 — Time-restricted Eating Acceptability, Efficacy and Safety in Obesity · NA · recruiting
NCT05727332 — Vascular Adaptations to Single-Sprint Training · NA · completed
NCT04280289 — CBD Cannabis Extract: Pharmacokinetic Studies · EARLY_PHASE1 · completed
NCT04570917 — Online Education Intervention to Reduce Ageism Among Undergraduate Students · NA · completed
NCT04073953 — Primaquine Enantiomers in G6PD Deficient Human Volunteers · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05908201 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Mississippi, Oxford
Last refreshed: 18 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05908201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing